GL1X · GenesisL1 explorer

Research workbench

Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH and a series of potent 5-(omega-CARBOXYL(ALKYLOXY) PYRIDO[2,-D]PYRIMIDINE derivatives

Analyse Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3NZB
Type
protein
Length
206 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P16184
Ligands
D2N, NDP
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XDihydrofolate reductase (EC 1.5.1.3)protein20627% helix, 30% strandP16184

Ligands and binding sites

  • D2N · ethyl 6-{3-[(2,4-diamino-5-methylpyrido[2,3-d]pyrimidin-6-yl)methyl]-4-methoxyphenoxy}hexanoate · ligand · 2 copies · chains X
  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14740.720.8248D2N, NDP

Compared structures

  • 3NZB · Structural Analysis of Pneumocystis carinii and Human DHFR Complexes with NADPH and a… · the same entry in another collection · chain X against X, TM-score 1.00
  • P16184 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P16184) · a predicted model of the same protein · chain X against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.